{"name": "PTC Therapeutics",
 "permalink": "ptc-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/ptc-therapeutics",
 "homepage_url": "http://www.ptcbio.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "PTCTherapeutics",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 1998,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@ptcbio.com",
 "phone_number": "908-222-7000",
 "description": "",
 "created_at": "Thu Dec 03 01:56:21 UTC 2009",
 "updated_at": "Thu Jun 06 10:19:10 UTC 2013",
 "overview": "\u003Cp\u003EPTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       69],
      "assets/images/resized/0006/8365/68365v1-max-150x150.jpg"],
     [[208,
       97],
      "assets/images/resized/0006/8365/68365v1-max-250x250.jpg"],
     [[208,
       97],
      "assets/images/resized/0006/8365/68365v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Stuart",
      "last_name": "W. Peltz",
      "permalink": "stuart-w-peltz",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "William",
      "last_name": "Baird, III",
      "permalink": "william-baird-iii",
      "image": null}},
   {"is_past": false,
    "title": "CMO",
    "person":
     {"first_name": "Langdon",
      "last_name": "L. Miller",
      "permalink": "langdon-l-miller",
      "image": null}},
   {"is_past": false,
    "title": "",
    "person":
     {"first_name": "Peter",
      "last_name": "Svennilson",
      "permalink": "peter-svennilson",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$177M",
 "funding_rounds":
  [{"round_code": "grant",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29\u0026aid=DJFVLS0020091202e5c20008d\u0026r=Rss\u0026s=DJFVLS",
    "source_description": "PTC Thera Wins Grant, Continues Non-Dilutive Funding Strategy",
    "raised_amount": 1000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 2,
    "investments":
     []},
   {"round_code": "e",
    "source_url": "http://www.finsmes.com/2009/12/ptc-therapeutics-raises-50m-in-equity.html",
    "source_description": "PTC Therapeutics Raises 50M in Equity Financing",
    "raised_amount": 50000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 12,
    "funded_day": 22,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Delphi Ventures",
         "permalink": "delphi-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/5369/45369v1-max-150x150.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-250x250.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Credit Suisse",
         "permalink": "credit-suisse",
         "image":
          {"available_sizes":
            [[[150,
               27],
              "assets/images/resized/0002/9146/29146v1-max-150x150.jpg"],
             [[175,
               32],
              "assets/images/resized/0002/9146/29146v1-max-250x250.jpg"],
             [[175,
               32],
              "assets/images/resized/0002/9146/29146v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "The Column Group",
         "permalink": "the-column-group",
         "image":
          {"available_sizes":
            [[[150,
               105],
              "assets/images/resized/0004/9539/49539v1-max-150x150.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-250x250.png"],
             [[230,
               162],
              "assets/images/resized/0004/9539/49539v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://ptct.client.shareholder.com/releasedetail.cfm?ReleaseID=197021",
    "source_description": "PTC THERAPEUTICS RAISES $26.6 MILLION IN PRIVATE PLACEMENT FINANCING",
    "raised_amount": 26600000.0,
    "raised_currency_code": "USD",
    "funded_year": 2005,
    "funded_month": 11,
    "funded_day": 10,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "CSFB Private Equity",
         "permalink": "csfb-private-equity-3",
         "image":
          {"available_sizes":
            [[[150,
               41],
              "assets/images/resized/0010/1192/101192v1-max-150x150.jpg"],
             [[183,
               51],
              "assets/images/resized/0010/1192/101192v1-max-250x250.jpg"],
             [[183,
               51],
              "assets/images/resized/0010/1192/101192v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vulcan Capital",
         "permalink": "vulcan-capital",
         "image":
          {"available_sizes":
            [[[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-150x150.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-250x250.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Delphi Ventures",
         "permalink": "delphi-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/5369/45369v1-max-150x150.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-250x250.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Bay City Capital",
         "permalink": "bay-city-capital",
         "image":
          {"available_sizes":
            [[[150,
               24],
              "assets/images/resized/0004/8963/48963v1-max-150x150.png"],
             [[219,
               36],
              "assets/images/resized/0004/8963/48963v1-max-250x250.png"],
             [[219,
               36],
              "assets/images/resized/0004/8963/48963v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Bioventures",
         "permalink": "novartis-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0006/1683/61683v1-max-150x150.png"],
             [[250,
               98],
              "assets/images/resized/0006/1683/61683v1-max-250x250.png"],
             [[380,
               150],
              "assets/images/resized/0006/1683/61683v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Amgen Ventures",
         "permalink": "amgen-ventures",
         "image":
          {"available_sizes":
            [[[150,
               28],
              "assets/images/resized/0023/2414/232414v2-max-150x150.jpg"],
             [[250,
               47],
              "assets/images/resized/0023/2414/232414v2-max-250x250.jpg"],
             [[450,
               84],
              "assets/images/resized/0023/2414/232414v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCap",
         "permalink": "healthcap",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0005/4096/54096v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0005/4096/54096v1-max-250x250.png"],
             [[450,
               139],
              "assets/images/resized/0005/4096/54096v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2011/12/ptc-therapeutics-receives-5m-seeding-drug-discovery-sdd-award-wellcome-trust.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "PTC Therapeutics Receives $5M Seeding Drug Discovery (SDD) Award from the Wellcome Trust",
    "raised_amount": 5000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Wellcome Trust",
         "permalink": "wellcome-trust",
         "image":
          {"available_sizes":
            [[[150,
               12],
              "assets/images/resized/0002/9701/29701v2-max-150x150.jpg"],
             [[250,
               20],
              "assets/images/resized/0002/9701/29701v2-max-250x250.jpg"],
             [[450,
               37],
              "assets/images/resized/0002/9701/29701v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2012/07/ptc-therapeutics-completes-30m-financing.html?utm_source=feedburner\u0026utm_medium=feed\u0026utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29",
    "source_description": "PTC Therapeutics Completes $30M Financing",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 7,
    "funded_day": 23,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Credit Suisse First Boston Next Fund",
         "permalink": "credit-suisse-first-boston-next-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HBM BioVentures",
         "permalink": "hbm-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0482/50482v1-max-150x150.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-250x250.png"],
             [[156,
               27],
              "assets/images/resized/0005/0482/50482v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Delphi Ventures",
         "permalink": "delphi-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/5369/45369v1-max-150x150.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-250x250.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "unattributed",
    "source_url": "http://www.finsmes.com/2013/03/ptc-therapeutics-completes-60m-financing.html",
    "source_description": "PTC Therapeutics Completes $60M Financing",
    "raised_amount": 60000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 7,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Brookside Capital",
         "permalink": "brookside-capital",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0000/3991/3991v1-max-150x150.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-250x250.png"],
             [[200,
               24],
              "assets/images/resized/0000/3991/3991v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Adage Capital Management",
         "permalink": "adage-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               13],
              "assets/images/resized/0004/6501/46501v1-max-150x150.jpg"],
             [[250,
               23],
              "assets/images/resized/0004/6501/46501v1-max-250x250.jpg"],
             [[422,
               39],
              "assets/images/resized/0004/6501/46501v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Jennison Associates",
         "permalink": "jennison-associates",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0008/4571/84571v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0008/4571/84571v1-max-250x250.jpg"],
             [[393,
               55],
              "assets/images/resized/0008/4571/84571v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Longwood Founders Fund",
         "permalink": "longwood-founders-fund",
         "image":
          {"available_sizes":
            [[[150,
               46],
              "assets/images/resized/0025/9573/259573v1-max-150x150.png"],
             [[250,
               77],
              "assets/images/resized/0025/9573/259573v1-max-250x250.png"],
             [[431,
               133],
              "assets/images/resized/0025/9573/259573v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Credit Suisse First Boston Next Fund",
         "permalink": "credit-suisse-first-boston-next-fund",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Vulcan Capital",
         "permalink": "vulcan-capital",
         "image":
          {"available_sizes":
            [[[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-150x150.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-250x250.png"],
             [[85,
               83],
              "assets/images/resized/0000/3532/3532v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Delphi Ventures",
         "permalink": "delphi-ventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0004/5369/45369v1-max-150x150.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-250x250.png"],
             [[206,
               82],
              "assets/images/resized/0004/5369/45369v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novo A/S",
         "permalink": "novo-a-s",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0025/1103/251103v1-max-150x150.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-250x250.png"],
             [[250,
               99],
              "assets/images/resized/0025/1103/251103v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "private_equity",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1070081/000107008113000003/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 4500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 15,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "100 Corporate Court",
    "address2": "",
    "zip_code": "07080-2449",
    "city": "South Plainfield",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo":
  {"valuation_amount": 322000000.0,
   "valuation_currency_code": "USD",
   "pub_year": 2013,
   "pub_month": 6,
   "pub_day": 5,
   "stock_symbol": "NASDAQ:PTCT"},
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0006/8364/68364v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0006/8364/68364v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0006/8364/68364v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}